Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
Zhongyun Dong(University of Cincinnati Medical Center), Shan Lu(University of Cincinnati Medical Center)
Cited by 92
Related Papers
Small-Molecule Targeting of Proliferating Cell Nuclear Antigen Chromatin Association Inhibits Tumor Cell Growth
|Molecular Pharmacology|2012|102
Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer
|Molecular Endocrinology|2006|81
Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
|International Journal of Oncology|2014|34
Target validation and structure–activity analysis of a series of novel <scp>PCNA</scp> inhibitors
|Pharmacology Research & Perspectives|2015|25